Jefferies Group LLC Guardant Health, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 50,228 shares of GH stock, worth $1.59 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

50,228

Previous 64,033 21.56%

Holding current value

$1.59 Million

Previous $2.58 Million 4.65%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$43.66 - $61.0 $602,726 - $842,105	-13,805 Reduced 21.56%	50,228 $2.7 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $372,201 - $520,025	-8,525 Reduced 13.31%	55,508 $2.71 Million
Q2 2022 Sep 21, 2023	BUY	$28.82 - $77.35 $1.68 Million - $4.5 Million	58,148 Added 988.07%	64,033 $2.58 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $1.67 Million - $4.48 Million	57,968 Added 955.78%	64,033 $2.58 Million
Q1 2022 Sep 21, 2023	SELL	$48.25 - $100.49 $384,456 - $800,704	-7,968 Reduced 57.52%	5,885 $389,000
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $375,771 - $782,616	-7,788 Reduced 56.22%	6,065 $392,000
Q4 2021 Sep 21, 2023	BUY	$88.71 - $120.43 $685,905 - $931,164	7,732 Added 126.32%	13,853 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $685,905 - $931,164	7,732 Added 126.32%	13,853 $1.39 Million
Q3 2021 Sep 21, 2023	SELL	$98.77 - $132.17 $2.66 Million - $3.56 Million	-26,914 Reduced 81.47%	6,121 $765,000
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $2.66 Million - $3.56 Million	-26,914 Reduced 81.47%	6,121 $765,000
Q2 2021 Sep 21, 2023	BUY	$109.77 - $165.68 $470,583 - $710,270	4,287 Added 14.91%	33,035 $4.1 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $470,583 - $710,270	4,287 Added 14.91%	33,035 $4.1 Million
Q1 2021 Sep 21, 2023	SELL	$127.04 - $179.1 $260,686 - $367,513	-2,052 Reduced 6.66%	28,748 $4.39 Million
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $260,686 - $367,513	-2,052 Reduced 6.66%	28,748 $4.39 Million
Q4 2020 Sep 21, 2023	SELL	$99.96 - $135.93 $2.47 Million - $3.36 Million	-24,708 Reduced 44.51%	30,800 $3.97 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $2.77 Million - $3.77 Million	27,758 Added 912.49%	30,800 $3.97 Million
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $1.96 Million - $2.73 Million	-24,458 Reduced 88.94%	3,042 $340,000
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $1.66 Million - $2.68 Million	27,500 New	27,500 $2.23 Million
Q4 2019 Feb 13, 2020	SELL	$59.49 - $82.78 $1.67 Million - $2.32 Million	-28,071 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$62.59 - $110.3 $1.5 Million - $2.65 Million	24,011 Added 591.4%	28,071 $1.79 Million
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $72,891 - $103,865	-1,140 Reduced 21.92%	4,060 $350,000
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $178,359 - $509,496	5,200 New	5,200 $399,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Guardant Health, Inc. Transaction History